S-methylisothiourea sulfate improves renal, but not hepatic dysfunction in canine endotoxic shock model

Intensive Care Medicine

Volumn 26, Issue 1, 2000, Pages 117-124

  Mitaka, C ^a   Hirata, Y ^a   Masaki, Y ^a   Takei, T ^a   Yokoyama, K ^a   Imai, T ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Endotoxic shock; Hemodynamic parameters; Hepatic dysfunction; Nitric oxide synthase inhibitor; Renal dysfunction; S methylisothiourea

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; BICARBONATE; BILIRUBIN; CREATININE; DRUG VEHICLE; LACTIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; S METHYLISOTHIOUREA SULFATE; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DRUG INDUCED DISEASE; DRUG INHIBITION; HEART FAILURE; HEMODYNAMICS; HYPERLACTATEMIA; HYPOTENSION; INTENSIVE CARE; KIDNEY FAILURE; LACTIC ACIDOSIS; LIVER DYSFUNCTION; MALE; NONHUMAN; SEPTIC SHOCK; THROMBOCYTOPENIA; VENTILATOR;

EID: 0034025941     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050023     Document Type: Article

References (31)

1. 1. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric Oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
2. 2. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064
3. 3. Kilbourn RG, Griffith OWP (1992) Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84: 827-831
4. 4. Thiemermann C, Vane JR (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharide in the rat in vivo. Eur J Pharmacol 182: 591-595
5. 5. Szabó C, Mitchell JA, Thiemermann C, Vane JR (1993) Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108: 786-792
6. 6. Cobb JP, Natanson C, Quezado ZMN, Hoffman WD, Koev CA, Banks S, Correa R, Levi R, Elin RJ, Hosseini JM, Danner RL (1995) Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 268:H1634-H1642
7. 7. Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26: 48-57
8. 2 delivery in septic dogs. Am J Physiol 268:H2017-2023
9. 9. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa JB, Curran RD, Simmons RL (1992) Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 20: 1568-1574
10. 10. Mitaka C, Hirata Y, Ichikawa K, Uchida T, Yokoyama K, Amaha K (1996) Effect of aminoguanidine, a more selective inhibitor for inducible nitric oxide synthase, on cardiovascular changes in endotoxin shock dogs. Appl Cardiopulm Pathophysiol 6: 145-150
11. 11. Szabó C, Southan GJ, Thiemermann C: (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91: 12472-12476
12. 12. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP (1996) A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 5: 116-121
13. 13. Cain S, Curtis SE (1991) Experimental models of pathologic oxygen supply dependency. Crit Care Med 19: 603-612
14. 14. Southan GJ, Szabó C, Thiemermann C (1995) Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114: 510-516
15. 15. Salvemini D, Korbut R, Anggard E (1990) Immediate release of nitric oxide-like factor from bovine aortic endothelial cells by E. coli lipopolysaccharide. Proc Natl Acad Sci USA 87: 2593-2597
16. 16. Abel FL (1989) Myocardial function in sepsis and endotoxin shock. Am J Physiol 257:R1265-R1281
17. 17. Hung J, Lew WY (1993) Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ Res 73: 125-134
18. 18. Brady AJB, Poole-Wilson PA, Harding SE (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263:H1963-H1966
19. 19. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389
20. 20. Decking UKM, Flesche CW, Gödecke A, Schrader J (1995) Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 268:H2460-H2465
21. 21. Hayes MA, Timmins AC, Yau EH, Palazzo M, Watson D, Hinds CJ (1997) Oxygen transport patterns in patients with sepsis syndrome or septic shock:influence of treatment and relationship to outcome. Crit Care Med 25: 926-936
22. 22. Kilpatrick-Smith L, Erecinska M (1983) Cellular effects of endotoxin in vitro. I. Effect of endotoxin on mitochondrial substrate metabolism and intracellular calcium. Circ Shock 11: 85-99
23. 23. Levraut J, Ciebiera JP, Chave S, Rabary O, Jambou P, Carles M, Grimaud D (1998) Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 157: 1021-1026
24. 24. Ayuse T, Brienza N, Revelly JP, Boitnott JK, Robotham JL (1995) Role of nitric oxide in porcine liver circulation under normal and endotoxic conditions. J Appl Physiol 78: 1319-1329
25. 25. Vos TA, Gouw ASH, Klock PA, Havinga R, van Goor H, Huitema S, Roelofsen H, Kuipers F, Jansen PLM (1997) Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 113: 1323-1333
26. 26. Rosselet A, Feihl F, Markert M, Gnaegi A, Perret C, Liaudet L (1998) Selective iNOS inhibition is superior to norepinephrine in the treatment of rat of endotoxic shock. Am J Respir Crit Care Med 157: 162-170
27. 27. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H, Mudgett JS (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650
28. 28. Mitaka C, Hirata Y, Yokoyama K, Nagura T, Tsunoda Y, Amaha K (1999) Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonost. Crit Care Med 27: 146-153
29. 29. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW (1994) Nitric oxide: A mediator in rat tubular hypoxia/ reoxygenation injury. Proc Natl Acad Sci USA 91: 1691-1695
30. 30. Groeneveld PHP, Kwappenberg KMC, Langermans JAM, Nibbering PH, Curtis L (1996) Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis. Intensive Care Med 22: 1197-1202
31. G-monomethyl-L-arginine or indomethacin. J Pharmacol Exp Ther 272: 452-459